Researchers developed a combination therapy using the anticancer agent mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating vancomycin-resistant Enterococcus faecalis or VRE.
Researchers developed a combination therapy using the anticancer agent mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating vancomycin-resistant Enterococcus faecalis or VRE.